Inonotus obliquus
Key actions
Anti-inflammatoryAntimicrobialAntioxidantImmunomodulator / immune support
Traditional & clinical uses, by strength of evidence
- Arthritis / joint painTraditional
- Cold & fluTraditional
- Immune supportTraditional
- Infection (general)Traditional
- Inflammation (general)Traditional
- Metabolic supportTraditional
- Skin irritationTraditional
- WoundsTraditional
Selected studies & references
PreclinicalImpact of Incorporating Dried Chaga Mushroom (Inonotus obliquus) into Gluten-Free Bread on Its Antioxidant and Sensory Characteristics (2024)
PreclinicalInonotus obliquus aqueous extract inhibits intestinal inflammation and insulin metabolism defects in Drosophila (2024)
PreclinicalInonotus obliquus sclerotia epidermis were different from internal tissues in compound composition, antioxidant activity, and associated fungi (2023)
PreclinicalInonotus obliquus and its bioactive compounds alleviate non-alcoholic fatty liver disease via regulating FXR/SHP/SREBP-1c axis (2022)
PreclinicalInonotus obliquus aqueous extract prevents histopathological alterations in liver induced by environmental toxicant Microcystin (2022)
PreclinicalPolysaccharide derived from Inonotus obliquus inhibits lipopolysaccharide-induced acute endometritis in mice (2022)
All 16 studies in the Knowledge Finder →
Educational use only. This profile summarises traditional and scientific sources for reference. It is not medical advice and not a substitute for a qualified practitioner. Some plants carry safety cautions and drug interactions — always check before use.